Please assess the completion status of the following clinical trial:

Trial Title: Magnesium and Asthma - Clinical Trials

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
* Mild to moderate persistent asthma (NAEPP 1997 revised guidelines)~* Current use of inhaled beta-2- agonists or steroid inhaler therapy only (No use of prednisone in past 3 months)~* No use of products (i.e. antacids, laxatives, supplements) containing more than 50 mg Mg daily in the last 3 months~* No current use of theophylline, leukotriene antagonists, or other systemic immunomodulating compounds~* Nonsmoker~* No concurrent pulmonary disease (pulmonary hypertension, cystic fibrosis, sarcoidosis, bronchiectasis, hypersensitivity pneumonitis, restrictive lung disease, abnormal DLCOva)~* No concurrent medical diagnoses (alcoholism, coronary artery disease, diabetes, HIV infection, chronic hepatitis, uncontrolled hypertension, chronic renal failure or a psychiatric disorder that is judged to make full participation difficult)~* Not pregnant or lactating.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).